local anaesthetic agent
DESCRIPTION
LOCAL ANAESTHETIC AGENT. By Dr Nur Hafizah binti Ibrahim Moderator: Dr Najwa binti Mansor. OUTLINE OF PRESENTATION. Definition History Commercial Preparations Structure-activity Relationships Mechanism of Action Minimum Concentration Pharmacokinetics Toxicity . DEFINITION. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/1.jpg)
LOCAL ANAESTHETIC AGENT
By Dr Nur Hafizah binti IbrahimModerator: Dr Najwa binti Mansor
![Page 2: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/2.jpg)
OUTLINE OF PRESENTATION
• Definition• History• Commercial Preparations• Structure-activity Relationships• Mechanism of Action• Minimum Concentration• Pharmacokinetics • Toxicity
![Page 3: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/3.jpg)
DEFINITION• A drug that produce reversible conduction blockade of
impulses along central and peripheral nerve pathways after regional anesthesia, producing autonomic nervous system blockade, sensory anesthesia and skeletal muscle paralysis in the area innervated.
• Interruption of transmission of autonomic, somatic sensory and somatic motor impulses.
• Removal of the local anesthetic is followed by spontaneous and complete return of nerve conduction, with no evidence of structural damage to nerve fibers as a result of the drug’s effects.
![Page 4: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/4.jpg)
HISTORY
• Cocaine– 1st local anesthetic introduced by Kollar in 1884, for use in
opthalmology.– It is a naturally occurring compound extracted from leaves of
Erythroxylon coca, a plant growing in the Andes Mountains.– Halsted recognized the ability of injected cocaine to
interrupt nerve impulse conduction, leading to the introduction of peripheral nerve block anesthesia and spinal anesthesia.
– Another unique feature of this drug is the ability to produced localized vasoconstriction.
![Page 5: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/5.jpg)
• 1st synthetic local anesthetic was the ester derivative procaine, introduced by Einhorn in 1905.
• Lidocaine was synthesized as an amide local anesthetic by Lofgren in 1943.– It produces more rapid, intense and longer-lasting
effect that procaine.– It is also effective topically and a highly efficacious
cardiac antidysarhythmic drug.
![Page 6: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/6.jpg)
COMMERCIAL PREPARATIONS
• Poorly soluble in water – marketed most often as water-soluble hydrochloride salt.
• These HCl salts are acidic (pH 6) – contributing to the stability of LA.
• An acidic pH also important if epinephrine is present in LA solution, because this cathecolamine is unstable at alkaline pH.
• Sodium bisulphite (strongly acidic), may be added to LA-ephephrine solutions to prevent oxidative decomposition of epinephrine.
![Page 7: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/7.jpg)
STRUCTURE-ACTIVITY RELATIONSHIPS
• Consist of a lipophilic and a hydrophilic portion separated by connection hydrocarbon chain.
• Lipophilic group:– usually unsaturated aromatic ring such as paraaminobenzoic
acid.– Essential for anesthetic activity
• Hydrophilic group:– Usually a tertiary amine (diethylamine).
• A hydrocarbon chain (consist of ester or amide) links both portion to produce delicate balance between lipid solubility and water solubility
![Page 8: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/8.jpg)
Basic structure
![Page 9: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/9.jpg)
![Page 10: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/10.jpg)
![Page 11: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/11.jpg)
Classifications of LA
ESTER• Procaine• Tetracaine• Amethocaine• Cocaine
AMIDE• Lidocaine• Prilocaine• Bupivacaine• Articaine• Mepivacaine
***If the local anesthetic has two ‘i’s in its name, it’s an amide
![Page 12: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/12.jpg)
Properties of LA AgentsPROPERTIES ESTERS AMIDES
Metabolism Rapid – plasma cholinesterase
Slow – hepatic
Systemic toxicity Less likely More likely
Allergic reaction Possible – PABA derivatives
Very rare
Stability in solution
Breaks down in ampules (heat, sun)
Very stable chemically
Onset of action Slow as a general rule Moderate to fast
pKa’s Higher than pH = 7.4 (8.5-8.9)
Close to pH = 7.4 (7.6-8.1)
![Page 13: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/13.jpg)
Physicochemical properties• The chemical structure and physicochemical characteristics
of LA affect their clinical properties.• Modification of the chemical structure (lengthening of the
hydrocarbon chain within critical length or increasing the number of carbon atoms in the aromatic ring or tertiary amine) may alter lipid solubility, potency, rate of metabolism & duration of action
• In particular, these are modified by:– Lipid solubility– Protein binding– Dissociation constant (pKa value)
![Page 14: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/14.jpg)
• Lipid solubility– Lipid solubility of diff anesthetics governs their ability to
penetrate perineuronal tissues and neural membrane, and reaches their site of action in neuroplasm
– More lipid soluble penetrates membrane more easily, less molecule requires for nerve conduction blockade i.e. more potent
– E.g. Bupivacaine, levobupivacaine and ropivacaine are app 3-4x as potent as lidocaine or prilocaine due to differences in their lipid-solubility
![Page 15: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/15.jpg)
• Protein binding:– Tissue protein binding primarily affect the duration of
action of LA• plasma protein binding > longer duration of action
– Plasma protein binding acts as depot– Tissue receptor binding – removed at a slower rate – Examples:
• Procaine is not extensively bound to tissue protein, has short duration of action
• Bupivacaine, levobupivacaine & ropivacaine are extensively bound to plasma and tissue protein --- prolonged effect
![Page 16: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/16.jpg)
• Dissociation constant (pKa value)– pKa is equal to pH at which the concentration of
ionized base and non-ionized base are equal.– It can be used to calculate the proportion of 2
forms that are present in solution at diff pH valuespH = pKa + log 10 (BH+) / (B)
– For weak base, (unionised ) / (ionised) = 10 (pH- pKa)
![Page 17: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/17.jpg)
• Is the most important factor affecting rapidity of onset of action.
• pKa value governs the proportions of LA that is present in non-ionized form at physiological pH values and therefore available to diffuse across tissue barrier to its site of action.
• LA with a pKa near physiological pH will have a greater degree of unionized molecules → More LA diffused across membrane → rapid onset of action
![Page 18: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/18.jpg)
![Page 19: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/19.jpg)
MECHANISM OF ACTION• Modulated-receptor theory
• Frequency-dependent blockade
• Guarded-receptor theory
• Membrane Expansion theory
• Surface-charge theory
![Page 20: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/20.jpg)
Modulated-receptor Theory
• Bindings of LA is stereospecific and dependent on the conformation state of the Na channel.
• 3 functional states:– Activated, open– Inactivated/refractory, closed– Resting, closed
• LA has high affinity for the open and inactivated closed state and low affinity for the rested closed state.
![Page 21: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/21.jpg)
![Page 22: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/22.jpg)
![Page 23: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/23.jpg)
• LA prevents transmission of nerve impulses (conduction blockade) by inhibiting passage of Na ions through ion-selective Na channels in nerve membrane.
• Na channel itself is a specific receptor for LA molecules.• So, occlusion of open Na channel by LA molecules
contributes little to overall inhibition of Na permeability.• Failure of Na ion channel permeability to increase will
slows the rate of depolarization such that threshold potential is not reached and thus an action potential is not propagated
![Page 24: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/24.jpg)
Frequency-dependent blockade
• Defines a situation where the more frequent the channel are activated, the greater the degree of block produced.
• During action potential, LA exhibit higher affinity to receptor at Na channel.
• But when action potential is over, affinity is less and some unbind.
• If another action potential (frequency) arrives before all drugs unbound, and additional increment of blocking will occur.
![Page 25: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/25.jpg)
Guarded-receptor Theory
•The affinity towards receptor is constantly high in contrast to first theory which depend on conformational state of Na channel.•However the access of LA to the receptor is
limited by channel.
![Page 26: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/26.jpg)
Membrane expansion theory
• Lipophilic LA incorporated into lipid bilayer causing a volume expansion & distortion to the conformation of axonal membrane and hence the Na channel resulting in its inactivation.
• This is mediated by unionized forms.
![Page 27: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/27.jpg)
Surface charge theory
• The protonated form of LA neutralized the negative charge of membrane of the nerve which resulting in hyperpolarizing the nerve.
![Page 28: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/28.jpg)
MINIMUM CONCENTRATION
• Minimum concentration (Cm) of LA necessary to produce conduction blockade of nerve impulses.
• It is analogous to the MAC for inhaled anesthetic.• Influenced by:
– nerve diameter (↑D ↑Cm), – Myelinated nerve ↑Cm– Frequency of nerve stimulation (↑F ↓Cm) – Tissue pH (↑pH ↓Cm)
![Page 29: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/29.jpg)
• Differential Conduction Blockade:– Is illustrated by selective blockade of preganglionic
sympathetic nervous system B fibers using low concentration of LA.
– Slightly higher concentration of LA interrupt conduction in small C fibers and small-and-medium sized A fibers, with loss of sensation for pain and temperature.
– However touch, proprioception and motor function still intact.
– Sometimes misinterpreted as failure of LA in an anxious patient.
![Page 30: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/30.jpg)
PHARMACOKINETICS
• Absorption• Distribution• Metabolism• Excretion
![Page 31: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/31.jpg)
Absorption
• Influenced by :– Site of administration– Dosage– Vasoconstrictor effect– Pharmacologic characteristic of the drugs– Patient’s factor age, cardiovascular status and
hepatic function.
![Page 32: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/32.jpg)
• Site of administration:– Intravenous fastest– Mucuos membrane/trachea– Intercostal block– Caudal block– Epidural block– Brachial plexus block– Peripheral nerve block– Subcutaneous infiltration slowest
![Page 33: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/33.jpg)
• Dosage– Blood level of LA is related to total dose of drug rather than
specific volume or conc of solution– Linear relationship between total dose & peak blood
concentration achieved
• Patient’s factor– In pregnancy ↑ LA effect d/t ↓ protein binding– In abscess ↓ LA effect d/t more ionized fraction in acidic pH– In hyperkalemic state ↑ LA effect d/t more inactive channel
![Page 34: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/34.jpg)
• Vasoconstrictor effect:– Vasoconstriction at site of injection – ↓ rate of absorption, ↓ Systemic toxicity, ↑ duration of
action– By addition of adrenaline 5μg/ml (1:200 000)– Higher Dosage offers no additional benefits but increases
symphatomimetic activites– Ropivacaine & Cocaine has intrinsic vasoconstrictor
activities– Lignocaine, mepivacaine, bupivacaine, etidocaine exhibit
vasodilator effects
![Page 35: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/35.jpg)
• all local anesthetics possess some degree of vasoactivity; most producing some level of vasodilation
• ester local anesthetics are potent vasodilating drugs
• Procaine (Novocaine) possesses tremendous vasodilating abilities which are employed to halt arteriospasm (accidental IA injection)
![Page 36: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/36.jpg)
Specific properties of the drugs
↑ Lipid solubility reduced protein binding reduce rate of ↓ pKa absortion
Degree of ↓ molecular ionization weight
![Page 37: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/37.jpg)
Distribution
• Depends on organ uptake, which determined by:– Tissue perfusion– Tissue/blood partition coefficient– Tissue mass– Lung extraction– Placental transfer
![Page 38: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/38.jpg)
• Tissue perfussion:– highly diffuse organ (brain, lungs, liver, kidney & heart) are
responsible for initial rapid uptake– Followed by slower redistribution to moderately perfused tissue
(muscle & gut)
• Tissue/blood partition coefficient– strong plasma protein binding eg Bupivacaine, tends to retain LA in
the blood– Influence by changes in concentration of alpha1 acid glycoprotein
(eg; pregnancy, old age, concurrent liver disease)– high lipid solubility; facilitates tissue uptake
![Page 39: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/39.jpg)
• Tissue mass:– muscle provides greatest reservoir for LA agents d/t its
large mass
• Lung extraction:– First pass pulmonary extraction esp lidocaine,
bupivacaine & prilocaine.– Limit the concentration of drug that reaches systemic
circulation for distribution to the coronary and cerebral circulation.
![Page 40: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/40.jpg)
• Placental transfer:– Highly plasma protein binding LA limits diffusion across
placenta– Esters undergo rapid hydrolysis hence not available for
transfer across placenta– Acidosis in fetus, which may occur during prolonged labour,
can result in accumulation of LA molecules in the fetus (ion trapping)
– This results in an accumulated concentration of drug in the fetus for two reasons.
• once the drug becomes ionized it cannot readily diffuse back across the placenta. This is known as ion trapping.
• a concentration gradient of nonionized drug is maintained between the mother and the fetus.
![Page 41: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/41.jpg)
Ion trapping
• Fetal blood is slightly more acidic than maternal blood, with a pH about 0.1 unit less than maternal blood pH.
• The lower pH of fetal blood facilitates the fetal uptake of drugs that are basic.
• Weakly basic drugs, such as local anesthetics and opioids, that cross the placenta in the nonionized state become ionized in the fetal circulation
![Page 42: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/42.jpg)
Metabolism
![Page 43: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/43.jpg)
Metabolism of ESTER• Undergo hydrolysis by cholinesterase enzyme, in the plasma
and liver• Rate of hydrolysis varies, and resulting metabolites are
pharmacologically inactive• PABA may be associated with allergic reaction• Systemic toxicity is inversely propotional to the rate of
hydrolysis• In SAB, in view of lack of cholinesterase enzyme in
cerebrospinal fluid, so the termination of action of intrathecal LA depends on absorption into the blood stream.
![Page 44: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/44.jpg)
• Prolonged in neonates, liver dysfunction, ↑BUN, parturient and atypical plasma cholinesterase homozygotes activity only ~50% in the newborn and doesn’t reach adult values until about 1 yr
![Page 45: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/45.jpg)
Metabolism of AMIDE
• Metabolized by microsomal enzyme located primarily in the liver.
amide base
aminocarboxilic acid + cyclic aniline derivative ↓ ↓ N-dealkylation hydroxylation
• The rate of metabolism are more slower and complex as compared to ester
• Systemic toxicity are more likely.
![Page 46: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/46.jpg)
• initial reaction N-alkylation subsequently hydrolysis– exception to Prilocaine– hydrolysis take place first forming o-toluidine– further metabolized to 4 and 6-hydroxytoluidine– o-toluidine responsible in metHb in high doses
• Benzocaine also can cause metHb• Rx: methylene blue ( Fe3+ Fe2+ )
![Page 47: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/47.jpg)
![Page 48: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/48.jpg)
COCAINE
• an alkaloid derived from leaves of Erythroxylon coca
• at low dose :– produces a feeling of well-being and euphoria– BRADYCARDIA d/t central vagal stimulation– block uptake of noradrenaline results
vasoconstriction and mydriasis
![Page 49: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/49.jpg)
• At higher dose:– stimulates vomiting center– central and peripheral sympath stimulation
• tachycardia• ↑ capacity muscular work
– eventually causes• Convulsion• coma• myocardial depression• medullary depression• respiratory depression• VF and DEATH
![Page 50: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/50.jpg)
•cocaine blocks conduction when applied directly to nerve tissue & may therefore be used in surface anesthesia
•cocaine was used in the past for ophthalmological procedures, however has now been abandoned• due to sloughing of the corneal epithelium & increased
intraocular pressure•the only use today is as a topical local anaesthetic in ENT
(5%)•cocaine itself constricts blood vessels and the use of
adrenaline is contraindicated as it sensitizes the myocardium
![Page 51: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/51.jpg)
Chloroprocaine
• Chloroprocaine is halogenated Procaine with additional chlorine atom
• short duration of action d/t ↑ 3-4 x rate of metabolism• low toxicity• less allergenic compare to procaine• rapid onset
![Page 52: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/52.jpg)
• is a halogenated derivative of procaine and has similar pharmacological properties
• the rapid plasma hydrolysis results in a short duration of action and low toxicity (potency = 1.0)
• onset of action is ~ 6-12 mins and the duration ~ 60 mins, depending upon the administered dose
• maximal recommended doses are 1000 & 800 mg, with and without adrenaline
• it is ineffective for topical anaesthesia but suitable for infiltration, or peripheral nerve block in a 1.0% solution
![Page 53: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/53.jpg)
• the low toxicity, short duration, rapid metabolism and low foetal:maternal blood partitioning make it a suitable choice in obstetrics
• suspected neural toxicity with epidural/spinal administration actually related to the addition of sodium bisulphite to the adrenaline containing solutions
• this was enhanced by the low pH of the solution and the limited buffering in the subarachnoid space
![Page 54: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/54.jpg)
Tetracaine • this is also an ester of PABA but is a potent, long acting
agent which is hydrolysed at a much slower rate• its actions are similar to those in this group• suitable for spinal anaesthesia, hypo & hyperbaric, in a 1.0%
solution when the dose ranges from 5.0 to 20 mg• onset of action is ~ 10 mins and the duration of action 60 to
90 mins• maximum recommended dose is ~ 100 mg for a 70 kg male• NB: this is a useful agent when the amide agents are
contraindicated
![Page 55: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/55.jpg)
Lignocaine
• Etidocaine derived from Lignocaine subtitution of ethyl group make it 50x more lipid soluble ↑2-3x duration of action (more longer than Bupi)
![Page 56: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/56.jpg)
• Structure – Amide LA; derivative of diethylaminoacetic acid
• Presentation – Clear aq solution lidocaine hydrochloride– Plain 0.5% (local infiltration) 1%, 2%(nerve blocks,
extradural anaesthesia)– with adrenaline 1:200 000– Gel 2% with or without chlorhexidine– 4% aq solution for topical application to pharynx,
larynx, trachea– 10% spray for oral cavity & upper resp tract
![Page 57: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/57.jpg)
• Recommended max dose 3mg/kg (7mg/kg with adrenaline)
• Acute ventricular dysrhythmia (class 1) – 1mg/kg over 2 min followed by infusion 4mg/min (1st hr), 2mg/min (2nd hr) & subsequently 1mg/min.
• Reduce stress response – 1-2mg/kg IV 5min before intubation
![Page 58: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/58.jpg)
• Clinically:– acts in 2-20min; duration 60-120min depending
on conc, vasoconst– CVS therapeutic & toxic effect– RS bronchodilation in subtoxic dose
• Pharmacokinetic MW pKa Part coef
234 7.9 2.9• Absorption – bioavailability by oral route is 24-46%
due to high extraction & 1st pass hepatic metabolism
![Page 59: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/59.jpg)
•Distribution Prot bind Vd
70% 0.75-1.5L/kg•Metabolism – 70% metabolised in liver by N-
dealkylation to MEGX, GX with further hydrolysis prior to renal excretion
• Excretion - <10% excreted unchanged• Cl – 6.8-11.6ml/kg/min t½ - 90-110min
![Page 60: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/60.jpg)
Bupivacaine
has butyl (C4H9) group to the piperidine N2, makes it more potent 35 timesand longer action 3-4 times compare toMepivacaine (methyl – CH3)
![Page 61: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/61.jpg)
• Structure – amide LA, pipecoloxylidide group, racemic
• Presentation – clear colourless, aq solution (bupivacaine hydrochloride )– Plain (0.25%, 0.5%, 0.75%)– With 1:200 000 (5µg/ml ) adrenaline– Heavy 0.5% with 80mg/ml dextrose (SG 1.026)
![Page 62: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/62.jpg)
• Recommended max dose 2mg/kg (150mg plus up to 50mg 2 hourly subsequently)
• Clinical - acts within 10-20min and almost immediate with intrathecal admin, duration of action 4-8hrs. 4X as potent as lignocaine
![Page 63: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/63.jpg)
• Pharmacokinetics MW pKa Part coef 288 8.1 27.5
• Absorption addition of adrenaline does not influence rate of systemic absorption
• Distribution : Prot bind Vd
95% 1L/kg(41-103L)• Metabolism liver microsomal enzymes P450 to 2,6-
Pipecoloxylidine (N-deakylation), N-desbutyl bupivacaine & 4OH bupivacaine also formed
• Excretion 5% excreted as PPX, 16% excreted unchanged in urine
• Cl : 0.47L/m t½ : 0.31-0.61Hr (after IV admin)
![Page 64: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/64.jpg)
•postoperative analgesia can be maintained for 3-4 hours with epidural blockade
•peak plasma levels following caudal or epidural administration are reached within 30-45 minutes, followed by decline over 3-6 hours
![Page 65: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/65.jpg)
• although more toxic, a lower foetal/maternal ratio has been observed cf. other agents
• thus, bupivacaine is the recommended for obstetric analgesia/anaesthesia, with the exception of paracervical block
• however, caution should be used with repeated doses• similarly, renal disease is unlikely to affect bupivacaine
clearance in the short term (~ 24 hrs),• however, toxicity may result with prolonged or repeated
administration
![Page 66: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/66.jpg)
Levobupivacaine
• Levobupivacaine is S enantiomer of Bupivacaine• Less cardio and CNS toxicity• Less vasodilation• 13% Less potent than bupivacaine
• less prolonged motor blockade but longer sensory blockade after epidural administration
![Page 67: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/67.jpg)
Ropivacaine
ropivacaine is single-enantiomer structurally resemble of Bupi/Mepivacaine with propyl (C3H7)group to the piperidine N2 atom
![Page 68: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/68.jpg)
• Ropivacaine is pure S-enantiomer of Bupivacaine• It’s potency, onset time and duration of action
almost identical to bupivacaine • less motor block• larger therapeutic index• 70% less cardiotoxic contribute fr its lower LIPID
SOLUBLE and its availability as S-isomer.
![Page 69: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/69.jpg)
• Structure – Amide LA, pipecoloxylidide group, pure S-enantiomer
• Presentation – Clear colourless solution containing 0.2/ 0.75/ 1.0% ropivacaine hydrochloride
• Recommended dose – 3.5mg/kg, 250mg (150mg for C-section under epidural), Cummulative dose 675mg over 24h according to data so far; not currently intended for intrathecal admin and in children < 12 years
![Page 70: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/70.jpg)
• Clinical – sensory blockade similar in time course to that produced by bupivacaine; motor blockade is slower in onset & shorter in duration than after an equivalent dose of bupivacaine; less cardiotoxic than bupivacaine; Intrinsic vasoconstrictor, mild CNS Sx
![Page 71: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/71.jpg)
• Pharmacokinetics MW pKa Part coef 274 8.1 6.1
• Distribution : Prot bind Vd 94% 0.8L/kg (52-66L)
• Metabolism occurs in liver to 2,6 pipecoloxylidine (N-deakylation), Aromatic hydroxylation to 3 & 4OH ropivacaine
• Excretion 86% (mostly conjugated) excreted in the urine, 1% unchanged
Cl – 0.82L/m t½ - 59-172min
![Page 72: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/72.jpg)
Prilocaine
• Prilocaine (CITANEST)• equipotent to lignocaine with a longer
duration of action and lower toxicity• rapid plasma hydrolysis makes it the agent of
choice for regional IV blockade• causes methaemoglobinaemia in high doses
but this is rarely clinically significant• used in all types of anaesthesia in similar
concentrations to lignocaine
![Page 73: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/73.jpg)
Mepivacaine
•used for infiltration, nerve block, caudal & epidural anaesthesia but is ineffective topically
•similar potency and onset to lignocaine but slightly longer duration of action
•used in similar concentrations to lignocaine•not recommended for obstetric use due to high
foetal:maternal ratio
![Page 74: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/74.jpg)
Etidocaine
• is a long acting derivative of lignocaine, with much higher lipid solubility and protein binding
• it is ~ 2-3 times more potent than lignocaine but less toxic than bupivacaine
• effective in infiltration, nerve block, epidural & caudal anaesthesia
• results in a high degree of motor blockade when administered into the epidural space
![Page 75: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/75.jpg)
![Page 76: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/76.jpg)
EMLA
• eutectic mixture of local anaesthetics is a 5% mixture of lignocaine (25 mg/g) &prilocaine base (25 mg/g)
• CONTACT TIME AT LEAST 1 HOUR• Duration of action 1-2 hr• Typically 1-2g applied to 10cm² area of skin
maximum 2000cm² in adult and 100cm² for child <10kg
![Page 77: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/77.jpg)
TOXICITY
• Occur due to excessive plasma and tissue concentrations of the LA.
• Common cause include accidental intravascular injection and overdose.
![Page 78: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/78.jpg)
![Page 79: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/79.jpg)
The relationship between lignocaine and plasma concentration and pharmacological effects
![Page 80: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/80.jpg)
Signs of toxicity BEGIN with numbness of the tongue/circumoral tissue
restless,vertigo,tinnitus,dizziness
slurred speech,skeletal ms twitching (face &
extrimities)
seizure-tonic-clonicdrowsiness
hypotension & apnea
ASYSTOLE
![Page 81: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/81.jpg)
CNS toxicity
• A relatively small dose (5 to 10ml lignocaine 1%) may cause ringing in the ears, a metallic taste in the mouth, numbness of the tongue, blurring of vision, drowsiness with decreased awareness, muscular twitching, restlessness and apprehension.
• With a larger dose, delirium may ensue and progress to grand mal convulsions.
• Asphyxia may develop if the convulsions are not treated rapidly and adequately.
![Page 82: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/82.jpg)
Cardiovascular toxicity
• In general LA depress myocardial automaticity • LA also ↓ duration of refractory period• At higher dose LA depress contractility and
conduction velocity• Prolongation PR and QRS interval on ECG• Myocardial depressant and vasodilatation lead to
HYPOTENSION• Cardiac dysrhythmia or circulatory collapse is often
the presenting sign of LA overdose during GA
![Page 83: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/83.jpg)
• Lignocaine is a less potent LA as compared to bupivacaine or ropivacaine and a higher dose is required to cause cardiovascular and CNS toxicity. The ratio of the dosage required for irreversible cardiovascular collapse (CVS) and the dosage that will produce CNS toxicity (convulsions), i.e. the CVS/CNS ratio, is lower for bupivacaine than for lignocaine.
• CVS/CNS dose ratio:– lignocaine 7.1– bupivacaine 3.7
• This indicates that 7 times as much lignocaine is required to induce irreversible CVS collapse as is needed to produce convulsions
![Page 84: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/84.jpg)
Treatment of LA toxicity
• Depends on severity, minor reaction - resolve spontaneously
• If seizures – protect airways, abort the seizures by midazolam, thiopentone, propofol
• If cardiac arrest - follow ACLS• IF NOT RESPONSIVE, intravenous lipid or
cardiopulonary bypass may be considered
![Page 85: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/85.jpg)
Management of severe LA toxicity
![Page 86: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/86.jpg)
![Page 87: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/87.jpg)
![Page 88: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/88.jpg)
by the Australian and New Zealand College of Anaesthetists (AN ZCA )
![Page 89: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/89.jpg)
Intravenous 20% lipid emulsion
• Was invented by Dr Weinberg, 1998• Rosenblatt 2006, first published rescue• Officially promoted as a treatment in Irelend
and British• The mechanism is not clear yet• it serve as lipid sink which capture the LA
molecules making then unavailable to tissue
![Page 90: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/90.jpg)
![Page 91: LOCAL ANAESTHETIC AGENT](https://reader031.vdocuments.site/reader031/viewer/2022020714/568163c3550346895dd4ec2a/html5/thumbnails/91.jpg)
• Changes during pregnancy:– Increased sensitivity (more rapid onset of conduction
blockade) may be present during pregnancy.– Alteration in protein-binding characteristics of
bupivacaine may result in increased concentration of pharmacologically active unbound drug in the parturient’s plasma.
– Nevertheless, progesterone, which binds to the same alpha1-acid glycoprotein as bupivacaine, does not influenced protein binding of this LA.
– This evidence suggest that bupivacaine and progesterone bind to discrete but separate sites on protein molecules.